Sanara MedTech Inc.
SMTI
$20.76
$0.391.92%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 1.95% | 10.23% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.95% | 10.23% | |||
| Cost of Revenue | -3.26% | 5.57% | |||
| Gross Profit | 2.37% | 10.62% | |||
| SG&A Expenses | -7.77% | 0.53% | |||
| Depreciation & Amortization | -45.17% | -0.91% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.55% | 1.36% | |||
| Operating Income | 9,496.81% | 98.50% | |||
| Income Before Tax | 141.34% | 42.78% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 141.34% | 42.78% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -75.00% | 1,900.00% | |||
| Net Income | -1,409.69% | 42.89% | |||
| EBIT | 9,496.81% | 98.50% | |||
| EBITDA | 232.97% | 213.32% | |||
| EPS Basic | -1,403.68% | 43.17% | |||
| Normalized Basic EPS | 141.37% | 43.39% | |||
| EPS Diluted | -1,355.71% | 43.17% | |||
| Normalized Diluted EPS | 140.00% | 43.39% | |||
| Average Basic Shares Outstanding | 0.39% | 0.50% | |||
| Average Diluted Shares Outstanding | 3.80% | 0.50% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||